Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation
Open Access
- 1 November 2003
- journal article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 9 (11) , S14-S20
- https://doi.org/10.1053/jlts.2003.50254
Abstract
Key points: 1. Chronic infection with hepatitis C virus (HCV) is the leading cause of cirrhosis and the most common indication for liver transplantation in many countries throughout the world. 2. The most significant factors leading to fibrosis progression in patients with chronic HCV infection include the degree of inflammation present on liver biopsy and ongoing alcohol use. 3. Patients with cirrhosis secondary to chronic HCV infection are at increased risk for developing hepatocellular carcinoma (HCC). 4. Achieving a sustained virological response after treatment with interferon, with or without ribavirin, is associated with a reduced risk for the development of cirrhosis and HCC and prolonged survival.Keywords
This publication has 45 references indexed in Scilit:
- Extrahepatic manifestations of hepatitis C among United States male veteransHepatology, 2002
- Durability of viral response to interferon ribavirin combination in patients with chronic hepatitis CJournal of Hepatology, 2001
- Chronic Infection with Hepatitis C Virus in Patients with Elevated or Persistently Normal Serum Alanine Aminotransferase Levels: Comparison of Hepatic Histology and Response to Interferon TherapyThe Journal of Infectious Diseases, 2000
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort StudyHepatology, 1998
- Impact of alcohol on the histological and clinical progression of Hepatitis C infectionHepatology, 1998
- Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver DiseasesLiver Transplantation and Surgery, 1997
- Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis CHepatology, 1997
- The Long–Term Pathological Evolution of Chronic Hepatitis CHepatology, 1996
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989